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ABSTRACT
• Standard postprandial triglycerides (TG) testing is time-consuming, tedious, and burdensome for 
the participant. Our laboratory has developed and validated a clinically feasible test for assessing 
postprandial TG known as the abbreviated fat tolerance test (AFTT) (2).
• For consistency and formulation of AFTT guidelines, it is critical that we determine whether 
moderate coffee intake prior to the AFTT modifies the postprandial TG response.
• Therefore, the purpose of this experiment was to determine the effect of coffee consumption prior 
to an AFTT on the validity of the AFTT. We hypothesized that coffee intake prior to an AFTT 
would result in a greater postprandial TG response compared to when a person does not consume 
coffee.
Participant and meal characteristics Individual postprandial TG responses for each meal trial for all 
participants.
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Objectives: Postprandial triglycerides (TG), or levels of fat in the blood after a meal, are an 
independent risk factor for cardiovascular disease (CVD) (1). A clinically feasible test to assess 
postprandial TG has been developed, known as the Abbreviated Fat Tolerance Test (AFTT) (2), 
however the impact of coffee consumption prior to an AFTT on postprandial TG is largely unknown. 
Considering that 50% of Americans consume one cup of coffee before or with breakfast (3), this 
study aimed to investigate the effect of coffee consumption prior to an AFTT on postprandial TG in 
order to determine if coffee intake prior to an AFTT affects its validity. Methods: Participants 
completed 2 randomized AFTTs separated by at least 1 week, but not exceeding 2 weeks. For each 
AFTT, participants arrived into the laboratory following a 10-hour overnight fast and consumed either 
1 cup of water or black coffee. Thirty-minutes later, a baseline blood draw was collected. 
Immediately following, the participant consumed a standardized high-fat shake, vacated the 
laboratory, and returned 4 hours later for a follow-up blood draw. Results: Six healthy individuals (3 
Women, 3 Men; age 21.3 ± 3.2; BMI 25.9 ± 1.6) completed the present study. Two-way ANOVA of 
TG revealed a significant overall time effect (p = 0.008), but not time x trial interaction (p = 0.87) or 
overall trial effect (p = 0.27). Absolute change in TG was not different between trials (p = 0.61). 
Conclusion:  In our small study sample, coffee intake prior to an AFTT did not affect postprandial TG. 
Therefore, coffee intake prior to an AFTT may not affect the validity of the AFTT. Further research 
should investigate the effects of coffee consumption prior to an AFTT on the validity of the AFTT in a 
larger, more diverse study population. 
We intended to recruit 10 participants (5 women, 5 men). Because of extenuating circumstances 
associated with the COVID-19 pandemic, 6 participants (3 W, 3 M) completed the present study:
• Age: 18-40 years
• Free of chronic disease or any dietary intolerances
• Not currently taking medications or supplements that alter metabolic outcomes such as TG or 
medications that alter blood pressure.
AFTT:
• Participants did not partake in planned exercise 2 days prior to each AFTT. 
• After consuming a provided snack (200 kcal) the night before each trial, participants completed a 
10-hour overnight fast prior to arriving to the laboratory. 
• On the morning of each trial, participants consumed either 8 ounces of black coffee or 8 ounces of 
water 30 minutes prior to their fasting blood draw.
• Participants consumed a high-fat shake containing vegan protein powder, chocolate syrup, and 
coconut cream (9kcal/kg body mass; 70% fat). 
• Participants were instructed to leave the laboratory for 4 hours post-meal consumption, abstaining 
from planned exercise and the consumption of food/drink other than water. They returned to the 
laboratory 4 hours post-meal consumption and a follow-up blood draw was collected.
Overall, coffee consumption prior to an AFTT did not 
affect postprandial TG.  
Water Coffee P-value
Glucose (mg/dL) 87.7 ± 4.7 88.7 ± 6.9 0.77
Total Cholesterol (mg/dL) 160.5 ± 64.2 160.2 ± 29.5 0.99
HDL-Cholesterol (mg/dL) 64.3 ± 15.0 57.8 ± 13.6 0.10
Figure 2. Postprandial TG responses. 
Postprandial TG responses in the 2 meal 
trials at baseline and 4 hours post-meal 
consumption. There were no significant 
differences at baseline or post-meal. Error 
bars indicate SD. 
Figure 4. Postprandial TG responses. Postprandial TG responses for each meal trial at baseline 
and 4 hours post-meal consumption for all participants (panels a-f). 
Table 2. Fasting metabolic outcomes. Metabolic outcomes represent fasting data for 
each meal trial averaged across participants. Data are presented as mean ± SD.
Table 1. Participant and meal characteristics. Participant characteristics represent 
values averaged across participants. Meal characteristics represent data for the high-
fat shake averaged across participants. Data are presented as mean ± SD. TG, 
triglycerides; BMI, body mass index; BP, blood pressure.
• In our small sample, consumption of coffee prior to the AFTT did not affect the postprandial TG 
response. 
• Therefore, the validity of the AFTT is preserved regardless of prior coffee consumption. 
• In order to employ these findings in the clinical setting, further research should be conducted in 
a larger sample size to determine the effect of coffee consumption prior to an AFTT on 
postprandial TG.
Figure 3. Absolute change in TG from 
baseline. Absolute change in TG from 
baseline in the 2 meal trials. Error bars 
indicate SD. Individual participant 
responses are represented by open circles 
(H20) or closed squares (COF). There 
were no significant differences between 
trials.
Total Men Women
Age 21.3 ± 3.2 23.7 ± 3.1 19.0 ± 0.0
Weight (kg) 74.5 ± 6.6 78.8 ± 6.5 70.1 ± 3.1
Height (cm) 171.7 ± 9.3 180 ± 3.0 163.3 ± 0.6
BMI (kg/m2) 25.9 ± 1.6 25.0 ± 1.2 26.9 ± 1.6
Systolic BP (mmHg) 114.5 ± 10.7 120.3 ± 8.0 108.7 ± 11.0
Diastolic BP (mmHg) 80.5 ± 12.3 80.7 ± 14.6 80.3 ± 12.9
Fat Mass (%) 24.8 ± 10.3 16.0 ± 5.6 33.7 ± 1.5
Skeletal Muscle Mass (%) 36.0 ± 5.8 41.0 ± 2.6 31.0 ± 0.1
Shake energy (kcal) 670.3 ± 59.4 709.5 ± 58.5 631.2 ± 28.2
Shake protein (g) 16.7 ± 1.5 17.7 ± 1.5 15.8 ± 0.7
Shake carbohydrate (g) 35.2 ± 3.1 37.2 ± 3.1 33.1 ± 1.5
Shake fat (g) 52.2 ± 4.6 55.2 ± 4.5 49.1 ± 2.3
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Figure 1. Schematic of AFTT protocol. In this randomized cross-over study, participants 
consumed 1 cup of water (H2O) or black coffee (COF) 30 minutes prior to the AFTT.
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